Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
0.9600
+0.0078 (0.82%)
Jan 28, 2026, 10:43 AM EST - Market open
Immuron Market Cap
Immuron has a market cap or net worth of $8.85 million as of January 28, 2026. Its market cap has decreased by -20.26% in one year.
Market Cap
8.85M
Enterprise Value
4.84M
1-Year Change
-20.26%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $8.85M, a decrease of -68.50%. That is a compound annual growth rate of -12.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 5.60M | 24.44% |
| Dec 31, 2025 | 4.50M | -53.61% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioVie | 9.12M |
| XTL Biopharmaceuticals | 9.10M |
| CytoMed Therapeutics | 9.00M |
| Ernexa Therapeutics | 8.95M |
| SeaStar Medical Holding | 8.63M |
| MetaVia | 8.38M |
| Alzamend Neuro | 8.21M |
| Aptevo Therapeutics | 8.19M |